Spyre Therapeutics
Cameron Turtle is a highly experienced professional who has held key leadership positions in various biotech and pharmaceutical companies. With a background in cardiovascular medicine and bioengineering, Cameron has worked on diverse topics such as M&A, growth strategy, clinical trials, and pricing. Currently serving as the Chief Executive Officer at Spyre Therapeutics, Cameron's career has been marked by a progression of strategic roles in the industry.
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.